Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
    • Partnerships
      • Companion diagnostics
ORDER
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk® gene table
      • Provider resources
        • Order a test
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
    • Partnerships
      • Companion diagnostics

Author: lbecz

  • Category
    • All
    • clinical
    • Counsyl Complete
    • Counsyl Culture
    • Engineering, Design and Analytics
    • Events
    • Genomics and Genetic Counseling
    • Human Understanding
    • News
    • Patients
    • Product
    • Reproductive Health
    • Stories
    • Uncategorized

NAVIGATING YOUR BREAST AND OVARIAN HEALTH IN THE (NEVER-ENDING) ERA OF COVID

It has been almost a year since most of us found ourselves in the completely unchartered territory of “sheltering in place” because of the rapid spread of C...

Read More

I Am Glad to Know: The Importance of Carrier Screening Through the Voice of a Carrier

This Sunday, February 28th, is #RareDiseaseDay! To raise awareness and support for the rare disease community, Myriad Women’s Health partnered with Taylor Kan...

Read More

Myriad’s 7 Greatest Hits in 2020

Before we say goodbye to 2020, we’d like to thank and recognize our partners. Together, we ensure patients have access to the transformative genetic insights ...

Read More

Knowledge is Power: How PKU Affected the Ahern Family

December 3rd is National PKU Day. PKU, short for phenylketonuria, is an inherited genetic condition in which the body cannot properly process the amino acid ph...

Read More

Simplify Patient Identification

Streamlining Cancer Risk Assessment with Digital Tools November is Family Health History Month and is a good time to bring awareness to the importance of collec...

Read More

Honoring Evan’s Memory: Raising Awareness About Tay-Sachs Disease

When I gave birth to my first child, Evan, in August of 1994, my husband Jeff and I were elated. After nine long months of anticipation, we were finally bles...

Read More

New York Photographer’s Connection to Breast Cancer Helps Shape Myriad’s New Message of Human Understanding

Meet Katie McCurdy*. She is a talented photographer who has traveled the world to create vibrant, expressive images that capture authentic and intimate m...

Read More

Integrating Genetic Testing into a Telehealth Program

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Read More

Remote Solutions to Assess Reproductive Risk

In March, ASRM recommended that fertility care providers delay any but the most urgent reproductive care cases to mitigate the spread of the COVID-19 virus1. W...

Read More

Telemedicine is not the future, it is NOW

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Read More

Planning a Pregnancy in the Post-COVID-19 World

“Plans are nothing, planning is everything.” - Dwight D. Eisenhower The start of the COVID-19 pandemic certainly disrupted daily life for most of the world....

Read More

Re-creating Patient /Provider Interaction: Telemedicine, The Next Frontier

Introducing Human Understanding a new podcast series from Myriad Women's Health. Each episode highlights real stories of providers in our communities who are m...

Read More

Virtual Risk Assessment and Patient Education Can Help Limit In-Person Exposure

In order to adapt to the changing healthcare environment and patients’ needs, Myriad has expanded its patient education services to support patients at home....

Read More

Supporting you and your patients through uncertain times

Over the past several weeks, incredible efforts have been made by healthcare professionals all over the world in response to the COVID-19 pandemic.  While...

Read More

Integrating Genetic Testing into a Telehealth Program

Dr. Candace Westgate*, an OB/GYN physician in California, explains her recent experience incorporating genetic testing through virtual visits into her practice...

Read More
  • 1
  • 2
  • 3
  • 4
  • 7
  • 8
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Myriad Genetics’ Blog
  • About
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Policy
  • HIPAA Notice of Privacy Practices
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.

  • © 2023 Myriad Genetics, Inc.